FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2901478468> ?p ?o ?g. }

• W2901478468 endingPage "709" @default.
• W2901478468 startingPage "697" @default.
• W2901478468 abstract "Abstract Chimeric antigen receptor T (CAR-T) cell therapy is a new pillar in cancer therapeutics; however, its application is limited by the associated toxicities. These include cytokine release syndrome (CRS) and neurotoxicity. Although the IL-6R antagonist tocilizumab is approved for treatment of CRS, there is no approved treatment of neurotoxicity associated with CD19-targeted CAR-T (CART19) cell therapy. Recent data suggest that monocytes and macrophages contribute to the development of CRS and neurotoxicity after CAR-T cell therapy. Therefore, we investigated neutralizing granulocyte-macrophage colony-stimulating factor (GM-CSF) as a potential strategy to manage CART19 cell–associated toxicities. In this study, we show that GM-CSF neutralization with lenzilumab does not inhibit CART19 cell function in vitro or in vivo. Moreover, CART19 cell proliferation was enhanced and durable control of leukemic disease was maintained better in patient-derived xenografts after GM-CSF neutralization with lenzilumab. In a patient acute lymphoblastic leukemia xenograft model of CRS and neuroinflammation (NI), GM-CSF neutralization resulted in a reduction of myeloid and T cell infiltration in the central nervous system and a significant reduction in NI and prevention of CRS. Finally, we generated GM-CSF–deficient CART19 cells through CRISPR/Cas9 disruption of GM-CSF during CAR-T cell manufacturing. These GM-CSFk/o CAR-T cells maintained normal functions and had enhanced antitumor activity in vivo, as well as improved overall survival, compared with CART19 cells. Together, these studies illuminate a novel approach to abrogate NI and CRS through GM-CSF neutralization, which may potentially enhance CAR-T cell function. Phase 2 studies with lenzilumab in combination with CART19 cell therapy are planned." @default.
• W2901478468 created "2018-11-29" @default.
• W2901478468 creator A5000383195 @default.
• W2901478468 creator A5002515721 @default.
• W2901478468 creator A5014701529 @default.
• W2901478468 creator A5022820232 @default.
• W2901478468 creator A5027944082 @default.
• W2901478468 creator A5028069544 @default.
• W2901478468 creator A5031780276 @default.
• W2901478468 creator A5032681443 @default.
• W2901478468 creator A5044624530 @default.
• W2901478468 creator A5047521482 @default.
• W2901478468 creator A5049052893 @default.
• W2901478468 creator A5054196868 @default.
• W2901478468 creator A5054678780 @default.
• W2901478468 creator A5060229988 @default.
• W2901478468 creator A5060299347 @default.
• W2901478468 creator A5063187039 @default.
• W2901478468 creator A5067492340 @default.
• W2901478468 creator A5069162526 @default.
• W2901478468 creator A5069962509 @default.
• W2901478468 creator A5072463255 @default.
• W2901478468 creator A5073731572 @default.
• W2901478468 creator A5084993777 @default.
• W2901478468 creator A5090781979 @default.
• W2901478468 date "2019-02-14" @default.
• W2901478468 modified "2023-10-18" @default.
• W2901478468 title "GM-CSF inhibition reduces cytokine release syndrome and neuroinflammation but enhances CAR-T cell function in xenografts" @default.
• W2901478468 cites W2023408885 @default.
• W2901478468 cites W2031211461 @default.
• W2901478468 cites W2031375393 @default.
• W2901478468 cites W2056589782 @default.
• W2901478468 cites W2082708772 @default.
• W2901478468 cites W2104133082 @default.
• W2901478468 cites W2105400883 @default.
• W2901478468 cites W2130011407 @default.
• W2901478468 cites W2167550136 @default.
• W2901478468 cites W2237472813 @default.
• W2901478468 cites W2340435799 @default.
• W2901478468 cites W2499095336 @default.
• W2901478468 cites W2519710256 @default.
• W2901478468 cites W2525215026 @default.
• W2901478468 cites W2579082802 @default.
• W2901478468 cites W2587691649 @default.
• W2901478468 cites W2603921376 @default.
• W2901478468 cites W2612001965 @default.
• W2901478468 cites W2620723923 @default.
• W2901478468 cites W2754562068 @default.
• W2901478468 cites W2763751953 @default.
• W2901478468 cites W2773804840 @default.
• W2901478468 cites W2775369717 @default.
• W2901478468 cites W2787301955 @default.
• W2901478468 cites W2791660181 @default.
• W2901478468 cites W2793826339 @default.
• W2901478468 cites W2804159084 @default.
• W2901478468 cites W2883690493 @default.
• W2901478468 cites W2890220179 @default.
• W2901478468 cites W2942621614 @default.
• W2901478468 doi "https://doi.org/10.1182/blood-2018-10-881722" @default.
• W2901478468 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6376281" @default.
• W2901478468 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30463995" @default.
• W2901478468 hasPublicationYear "2019" @default.
• W2901478468 type Work @default.
• W2901478468 sameAs 2901478468 @default.
• W2901478468 citedByCount "370" @default.
• W2901478468 countsByYear W29014784682019 @default.
• W2901478468 countsByYear W29014784682020 @default.
• W2901478468 countsByYear W29014784682021 @default.
• W2901478468 countsByYear W29014784682022 @default.
• W2901478468 countsByYear W29014784682023 @default.
• W2901478468 crossrefType "journal-article" @default.
• W2901478468 hasAuthorship W2901478468A5000383195 @default.
• W2901478468 hasAuthorship W2901478468A5002515721 @default.
• W2901478468 hasAuthorship W2901478468A5014701529 @default.
• W2901478468 hasAuthorship W2901478468A5022820232 @default.
• W2901478468 hasAuthorship W2901478468A5027944082 @default.
• W2901478468 hasAuthorship W2901478468A5028069544 @default.
• W2901478468 hasAuthorship W2901478468A5031780276 @default.
• W2901478468 hasAuthorship W2901478468A5032681443 @default.
• W2901478468 hasAuthorship W2901478468A5044624530 @default.
• W2901478468 hasAuthorship W2901478468A5047521482 @default.
• W2901478468 hasAuthorship W2901478468A5049052893 @default.
• W2901478468 hasAuthorship W2901478468A5054196868 @default.
• W2901478468 hasAuthorship W2901478468A5054678780 @default.
• W2901478468 hasAuthorship W2901478468A5060229988 @default.
• W2901478468 hasAuthorship W2901478468A5060299347 @default.
• W2901478468 hasAuthorship W2901478468A5063187039 @default.
• W2901478468 hasAuthorship W2901478468A5067492340 @default.
• W2901478468 hasAuthorship W2901478468A5069162526 @default.
• W2901478468 hasAuthorship W2901478468A5069962509 @default.
• W2901478468 hasAuthorship W2901478468A5072463255 @default.
• W2901478468 hasAuthorship W2901478468A5073731572 @default.
• W2901478468 hasAuthorship W2901478468A5084993777 @default.
• W2901478468 hasAuthorship W2901478468A5090781979 @default.
• W2901478468 hasBestOaLocation W29014784681 @default.
• W2901478468 hasConcept C126322002 @default.
• W2901478468 hasConcept C203014093 @default.
• W2901478468 hasConcept C2776090121 @default.

• next